June 24 (Reuters) - Pharmaust Ltd PAA.AX :
* MONEPANTEL & MONEPANTEL SULFONE TREATMENT BOTH REDUCE SARS-COV-2 CELL-TO-CELL INFECTIVITY IN CELL CULTURE
* VIRUS INFECTIVITY WAS SUPRESSED BY APPROXIMATELY 95% IN CELL CULTURE IN TESTS
* QUANTITIES OF MONEPANTEL REQUIRED TO INHIBIT COVID-19 VIRUS INFECTIVITY WERE IN CLINICALLY ACCEPTABLE RANGE